Skip to main content

Peer Review reports

From: LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR

Original Submission
26 Oct 2018 Submitted Original manuscript
13 Nov 2018 Author responded Author comments - Lu Wang
Resubmission - Version 2
13 Nov 2018 Submitted Manuscript version 2
9 Dec 2018 Reviewed Reviewer Report - Wenjun Shi
14 Dec 2018 Reviewed Reviewer Report - Spencer Gibson
8 Mar 2019 Author responded Author comments - Lu Wang
Resubmission - Version 3
8 Mar 2019 Submitted Manuscript version 3
19 Mar 2019 Author responded Author comments - Lu Wang
Resubmission - Version 4
19 Mar 2019 Submitted Manuscript version 4
Publishing
21 Mar 2019 Editorially accepted
2 Apr 2019 Article published 10.1186/s12885-019-5506-7

You can find further information about peer review here.

Back to article page